By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


RespireRx (Formerly Known As Cortex Pharmaceuticals, Inc.) 

15241 Barranca Parkway

Irvine  California  92718  U.S.A.
Phone: 949-727-3157 Fax: 949-727-3657



Company News
RespireRx  (RSRX) Files March 31, 2016 Quarterly Report On Form 10-Q 5/17/2016 12:23:34 PM
RespireRx  (RSRX), University of Alberta And University of Florida Provide Update On Collaborative Research Activities 4/1/2016 10:30:13 AM
RespireRx  (RSRX) Files December 31, 2015 Annual Report On Form 10-K 3/30/2016 10:28:17 AM
RespireRx  (RSRX) To Present At The 28th Annual Roth Conference On March 15, 2016 3/11/2016 8:56:00 AM
RespireRx  (RSRX) Announces Removal Of FDA Clinical Hold On CX1739 And Initiation Of Phase 2A Clinical Trial By March 31, 2016 2/29/2016 12:44:41 PM
RespireRx  (RSRX) To Present At 18th Annual BIO CEO & Investor Conference 2/5/2016 10:50:29 AM
RespireRx  (RSRX) Announces New Research Program With The National Institute Of Drug Abuse 1/19/2016 11:05:35 AM
RespireRx  (RSRX) To Present At Noble Financial Capital Markets' Twelfth Annual Investor/Equity Conference - NobleCon12 1/19/2016 10:56:46 AM
RespireRx  (RSRX) To Present At 8th Annual Biotech Showcase 2016 1/12/2016 2:28:06 PM
Cortex Pharmaceuticals, Inc. (COR) To Present At The 14th Annual BIO Investor Forum 10/19/2015 12:15:19 PM